CoChat

A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

There is evidence to support the view that glutamate hyperactivity might be relevant to the neurobiology of depersonalization. We tested the efficacy of lamotrigine, which reduces glutamate release, as a treatment for patients with depersonalization disorder. A double-blind, placebo-controlled, cross-over design was used to evaluate 12 weeks of treatment of lamotrigine. Subjects comprised nine patients with DSM-IV depersonalization disorder. Changes on the Cambridge Depersonalization Scale and the Present State Examination depersonalization/derealization items were compared across the two cross-over periods. Lamotrigine was not significantly superior to placebo. None of the nine patients was deemed a responder to the lamotrigine arm of the cross-over. Lamotrigine does not seem to be useful as a sole medication in the treatment of depersonalization disorder.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881103017001712

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 21 references

Research works printed but not linked: 5

  1. Chambers A C, 1999, Semin Clin Neuropsychiatry, 4, 274
  2. Dursun S M, 2001, J Psychiatry Neurosci, 26, 168
  3. Hollander E, 1990, J Clin Psychopharmacol, 3, 200
  4. 10.1002/(SICI)1098-2396(199611)24:3<248::AID-SYN7>3.0.CO;2-E · doi:10.1002/(sici)1098-2396(199611)24:3<248::aid-syn7>3.0.co;2-e
  5. Wing J K, 1974, The description and classification of psychiatric symptoms: an instruction manual for the PSE and CATEGO Program

Cited by

See all 73

Metadata

Authors
Sierra, M., Phillips, M. L., Ivin, G., Krystal, J., & David, A. S.
Affiliations
  • University of London (GB)
  • Maudsley Hospital (GB)
  • Yale University (US)
Venue
Journal of Psychopharmacology
Published
2003-01
Volume
17
Issue
1
Pages
103-105
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2134541433
Cited by
73
References
21
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 5 · 2016: 1 · 2015: 1 · 2014: 3 · 2013: 6 · 2012: 5
FWCI
2.87
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
lamotrigine, depersonalization disorder, depersonalization, derealization, glutamate release, antiepileptic drugs, pharmacotherapy, Present State Examination
MeSH terms
Lamotrigine, Adult, Analysis of Variance, Antidepressive Agents, Depersonalization, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Interview, Psychological, Male, Pilot Projects, Triazines, Treatment Outcome, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. https://app.cochat.ai/papers/10.1177/0269881103017001712
The paper
Sierra, M., Phillips, M. L., Ivin, G., Krystal, J., & David, A. S. (2003). A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. Journal of Psychopharmacology. https://doi.org/10.1177/0269881103017001712

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.